FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

FDA OKs Sanofi/Regeneron sBLA for Once-monthly Praluent

FDA approves a Sanofi and Regeneron Pharmaceuticals supplemental BLA for a once-monthly, 300 mg dose of Praluent (alirocumab) injection for treating a...

Human Drugs

Critics Say Gottlieb Helped Cephalon Get Fentanyl

Critics say that Scott Gottliebs efforts to help Cephalon obtain more fentanyl in 2006 when he was an FDA deputy commissioner shows that he is too clo...

Human Drugs

Court Sees Possible FDA Liability in Drug Compounding Case

A Massachusetts federal judge refuses to dismiss an argument from two medical practices that FDA was reckless in failing to act sufficiently against N...

Medical Devices

FDA Clears Diazyme Sepsis Assay

FDA clears a Diazyme Laboratories 510(k) for the Procalcitonin assay for use in diagnosing sepsis.

Federal Register

Vaccine Panel Meets on Respiratory Syncytial Virus

Federal Register notice: FDA announces a 5/17 Vaccines and Related Biological Products Advisory Committee meeting.

Medical Devices

Thermo Fisher, SpeeDx Partner on STD Detector

Thermo Fisher Scientific and SpeeDx agree to develop and submit for FDA clearance the ResistancePlus MG Test for detecting M. genitalium, a rapidly gr...

Human Drugs

Apotex Petitions to Hold Neulasta Biosimilars to Higher Approval Bar

Apotex petitions FDA to impose stricter approval requirements for applicants seeking approval for a biosimilar product referencing Amgens Neulasta (pe...

Human Drugs

Sanofi Gains Approval for Kidney Transplant Rejection Therapy

FDA approves Sanofis Thymoglobulin [anti-thymocyte globulin (rabbit)], for use in conjunction with concomitant immunosuppression to prevent acute reje...

Federal Register

Workshop on Reducing Hypoglycemia-related Adverse Events

Federal Register notice: CDER announces a one-day (9/12) public workshop on Reducing the Risk of Preventable Adverse Drug Events Associated with Hypog...

Human Drugs

FDA Releases Sun Form 483 After Latest Inspection in India

FDA cites Sun Pharmaceuticals with an 11-item Form 483 after completing a week-long inspection 4/13 at the firms Dadra, India finished-dosage drug man...